Asterion Cannabis Inc.

Recent News

  • Asterion Awarded Medicinal Cannabis Licences from the Australian Office of Drug Control

    Vancouver, British Columbia--(Newsfile Corp. - December 23, 2019) - Asterion Cannabis Inc. ("Asterion" or the "Company"), announces that its wholly-owned Australian subsidiary ("Asterion Australia") has received its licences for the cultivation, manufacturing and research of medicinal cannabis (the "Licences") from the Australian Government's Office of Drug Control ("ODC"), effective December 20, 2019."This is a major milestone for Asterion as it prepares to commence work on its industry leading medicinal cannabis cultivation and processing facility near Toowoomba in South East Queensland,...

    2019-12-23 9:00 AM ET
  • Asterion Lodges Operational Works Permit Application for Development at its Medicinal Cannabis Propagation and Processing Facility

    Vancouver, British Columbia--(Newsfile Corp. - November 12, 2019) - Asterion Cannabis Inc. ("Asterion" or the "Company") announces that the Company's wholly-owned Australian subsidiary ("Asterion Australia") has submitted its Operational Works permit (the "Operational Works Permit") application to the Toowoomba Regional Council (the "Council") to seek approval of certain development activities at the Company's Toowoomba Medicinal Cannabis project (the "Project"), as part of the final approval process for development of the Project.The Company recently received the required Development Approval permit (the...

    2019-11-12 10:00 AM ET
  • Asterion Receives Development Approval Permit for its Medicinal Cannabis Propagation and Processing Facility

    Vancouver, British Columbia--(Newsfile Corp. - November 6, 2019) - Asterion Cannabis Inc. ("Asterion" or the "Company") announces that the Company's wholly-owned Australian subsidiary ("Asterion Australia") has received the required Development Approval ("DA") permit from the Toowoomba Regional Council (the "Council") for the Company's Toowoomba Medicinal Cannabis Project (the "Project"). The DA means that the Council has accepted Asterion's proposed design and operational parameters for the Project, a 75 ha (185 acre) intensive horticulture project that includes 40 ha (4.3 million...

    2019-11-06 4:31 PM ET
  • Asterion Announces Appointment of Mr. Peter Ryan as Director of Development (Australia)

    Vancouver, British Columbia--(Newsfile Corp. - August 26, 2019) - Asterion Cannabis Inc. ("Asterion" or the "Company"), announces the appointment of Mr. Peter Ryan, PhD, BEng, BBus, MProMan, as the Director of Development (Australia).Mr. Ryan is an executive engineer and business leader with a track record of delivering strong operational results in organisations operating within the infrastructure and construction industry. Mr. Ryan's career spans over 25 years, during which time he has worked throughout Australia, South East Asia and...

    2019-08-26 11:20 AM ET
  • PreveCeutical Grants Asterion Option to Purchase up to a 51% Interest in Sol-Gel Intellectual Property

    Vancouver, British Columbia--(Newsfile Corp. - August 6, 2019) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) ("PreveCeutical"), and Asterion Cannabis Inc. ("Asterion") announce that they have entered into an option to purchase agreement (the "Option Agreement"), whereby PreveCeutical has granted to Asterion the right and option (the "Option") to purchase up to 51% of PreveCeutical's right, title and interest in and to certain intellectual property rights relating to a soluble gel ("Sol-Gel") nasal delivery system for the nose-to-brain...

    2019-08-06 3:16 PM ET
  • Asterion Cannabis Announces Annual General Meeting Results and Election of New Directors

    Vancouver, British Columbia--(Newsfile Corp. - July 4, 2019) - Asterion Cannabis Inc. ("Asterion" or the "Company"), is pleased to announce the voting results from the Company's 2019 annual general meeting of shareholders (the "Meeting") held on Thursday June 20, 2019 in Vancouver, British Columbia. A total of 35,798,667 common shares were voted at the Meeting, representing 55.08% of the outstanding common shares of the Company, as at the record date for the Meeting. All matters submitted to shareholders...

    2019-07-04 1:48 PM ET
  • Asterion Signs Equity Participation Agreement with Wellcamp Business Park Pty Ltd

    Vancouver, British Columbia--(Newsfile Corp. - June 19, 2019) - Asterion Cannabis Inc. ("Asterion" or the "Company"), announces that, further to its news release dated April 24, 2019, the Company and its wholly-owned Australian subsidiary ("Asterion Australia") have entered into an equity participation agreement dated June 18, 2019 (the "Equity Participation Agreement") with Wellcamp Business Park Pty Ltd ("Wellcamp"), [an affiliate of Wagners Properties Pty Ltd] ("Wagners"). Pursuant to the terms of the Equity Participation Agreement, Asterion and Asterion Australia have...

    2019-06-19 10:00 AM ET
  • Asterion Appoints John Wagner as Strategic Advisor

    Vancouver, British Columbia--(Newsfile Corp. - May 29, 2019) - Asterion Cannabis Inc. (P.ASTR) ("Asterion" or the "Company") and Asterion Australia Pty Ltd ("Asterion Australia"), the Company's wholly-owned subsidiary, announces that Asterion Australia has entered into a strategic advisory services agreement with Mr. John Wagner, a Non-Executive Director of Wagners Holding Company Limited (ASX: WGN) ("Wagners"). Pursuant to the agreement, Mr. Wagner has been appointed as a Strategic Advisor to the Board of Directors of Asterion Australia and Asterion's Chief Executive...

    2019-05-29 8:00 AM ET